The Federal Food And Drug Administration (FDA) approved the drug Triferic on January 26, 2015. Triferic is an iron replacement drug which is used during dialysis to replace iron and maintain consistent hemoglobin levels as a major side effect of dialysis is iron-deficiency anemia. The final approval from the FDA allows Rockwell to proceed with the manufacture and distribution of Triferic to dialysis centers. Triferic has been in development at Rockwell Medical Technologies in Wixom, Michigan. … [Read more...] about Triferic FDA Approved For Kidney Disease